New test of PML risk

A blood test of people who are JCV positive may be able to identify those with lower risk of PML who might be able to stay on treatment with natalizumab (Tysabri). A larger trial involving 342 people is underway. From ECTRIMS. MedPage Today Medscape (requires free registration) Natalizumab (Tysabri) - A to Z of MS PML (Progressive multifocal leukoencephalopathy) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news